Figure 1, Figure 2 and Figure 3 present the statistical distribution of stromelysins (MMP-3 and MMP-10), matrilysins (MMP-7, MMP-26), and comparative markers (CA125, SCC-Ag) in cervical cancer patients (CC), cervical dysplasia patients (CD), and the healthy control (HC) group. This evidence concerns the gene MMP10 and cervical cancer.